External Genitalia

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC37-20

DiraChart Clinical Reference
Protected section 20 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 20 of 25PreviousNext

16. Weak vs. strong documentation

Paired entries for this system. The left column is denial-bait; the right column is the same clinical picture written so a reviewer can see why a nurse was required.

Weak — does not survive

Why it fails

Strong — defensible

“Skin okay.”

No exam, no consent/chaperone note, no dermatitis-vs-PI distinction — a layperson observation.

“Perineal skin assessment with consent and chaperone per policy: intact, no dermatitis or breakdown; barrier effective; device entry-site intact.”

“Rash down there.”

No differentiation, no barrier plan, no action.

“Diffuse moisture-pattern erythema with denudation in skin folds — incontinence-associated dermatitis, not pressure injury; barrier protocol started; MD notified.”

“Bedsore on bottom.”

No staging, no offloading, no differentiation.

“Stage 3 sacral pressure injury over the bony prominence, distinct from surrounding dermatitis; offloaded, wound care per order; MD notified (see Wounds).”

“Very sore, looks dark.”

No necrotizing-infection recognition, no escalation.

“Perineal pain out of proportion with dusky skin, crepitus, and fever; concerning for Fournier’s gangrene; EMS activated; MD notified.”

“Educated on skin care.”

No content, no learner response.

“Perineal care and barrier application taught; caregiver return-demonstrated gentle cleansing and barrier use; warning signs of infection reviewed.”

“Catheter site fine.”

No meatal/entry-site detail, no securement.

“Meatus and catheter securement site intact without erythema or trauma; secured without traction; entry-site care reinforced (see Urinary/Renal).”

Section NavigationPart 20 of 25PreviousNext